A carregar...
EXTH-19. COMBINATION OF IN VITRO TUMOR TREATING FIELDS AND TEMOZOLOMIDE DECREASE PROLIFERATION IN PATIENT-DERIVED GLIOBLASTOMA CELL LINES
BACKGROUND: Tumor treating fields (TTFields) are FDA-approved for treatment of newly-diagnosed and recurrent glioblastoma. Adding TTFields therapy to standard-of-care temozolomide (TMZ) extended progression-free survival and overall survival in newly-diagnosed glioblastoma patients. In this study, c...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692458/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.314 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|